Eco Med Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 05-12-2024
- Paid Up Capital ₹ 0.50 M
as on 05-12-2024
- Company Age 13 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.40 M
as on 05-12-2024
- Revenue 28.17%
(FY 2022)
- Profit 107.14%
(FY 2022)
- Ebitda 69.51%
(FY 2022)
- Net Worth 36.91%
(FY 2022)
- Total Assets 5.44%
(FY 2022)
About Eco Med Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹2.40 M.
Vinod Kumar and Neelam Sharma serve as directors at the Company.
- CIN/LLPIN
U24232HP2011PTC031550
- Company No.
031550
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Jan 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Kullu, Himachal Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Eco Med Lifesciences Private Limited offer?
Eco Med Lifesciences Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Blood Pressure Medicine, Digestive System Drugs & Medicines, Pre & Probiotic Capsule, Pain Relief Drugs & Pharmaceuticals, Muscle Relaxant, Antacid Drugs, Respiratory System Drugs, Anti Asthma Drug, Nutraceuticals & Dietary Supplements.
Who are the key members and board of directors at Eco Med Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vinod Kumar  | Director | 31-Jan-2011 | Current |
| Neelam Sharma | Director | 31-Jan-2011 | Current |
Financial Performance of Eco Med Lifesciences.
Eco Med Lifesciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 28.17% increase. The company also saw a substantial improvement in profitability, with a 107.14% increase in profit. The company's net worth Soared by an impressive increase of 36.91%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Eco Med Lifesciences?
In 2020, Eco Med Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 05 Sep 2014 | ₹2.40 M | Open |
How Many Employees Work at Eco Med Lifesciences?
Eco Med Lifesciences has a workforce of 19 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Eco Med Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Eco Med Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
